Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases.

Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases. - Re-irradiation SBRT for painful spinal metastases.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036849

Enrollment

Registered

2019-07-01

Start date

2019-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painful spinal bone metastases

Interventions

SBRT of 24 Gy in 2 fractions for painful spinal bone metastases.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. pathological or clinical diagnosis of non-spine bone metastases 2. painful spinal bone metastases with NRPS of 2 or more 3. painful spinal bone metastases had history of irradiation at least once 4. An hour resting in supine is possible 5. Age; 20- 6. Expected prognosis; 6 months or more 7. Written informed consent

Exclusion criteria

Exclusion criteria: 1. The lesion is radiosensitive tumor 2. Need to surgical intervention due to spinal cord compression 3. Radiation history in same area within 3 months 4. Stereotactic body radiation therapy history in same area 5. Serious medical or psychological problems

Design outcomes

Primary

Measure	Time frame
Pain progression-free rate at 6 months	—

Countries

Japan

Contacts

Public ContactHiroaki Ogawa

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Radiation Oncology

hogawa@cick.jp03-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026